Patent details

Basic Information

Publication number:

EP2417146

PCT Application Number:

PCT/US/2010/030073

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107137549

PCT Publication Number:

WO/2010/118006

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

(2'-DEOXY-RIBOFURANOSYL)-1,3,4,7-TETRAHYDRO-(1,3)DIAZEPIN-2-ONE DERIVATIVES FOR TREATING CANCER

French Title of Invention:

(2'-DESOXY-RIBOFURANOSYL)-1,3,4,7-TETRAHYDRO-(1,3)DIAZEPIN-2-ON DERIVATE ZUR BEHANDLUNG VON KREBS

German Title of Invention:

DERIVES DE LA (2'-DEOXY-RIBOFURANOSYL)-1,3,4,7-TETRAHYDRO-(1,3)DIAZEPIN-2-ONE POUR LE TRAITMENT DU CANCER

SPC Number:

Dates

Filing date:

06/04/2010

Grant date:

13/07/2016

EP Publication Date:

13/07/2016

PCT Publication Date:

14/10/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/02/2012

EP B1 Publication Date:

13/07/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/04/2017

Expiration date:

06/04/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/04/2010

 

 

Name:

Otsuka Pharmaceutical Co. Ltd.

Address:

2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo 101-8535, Japan (JP)

Inventor

1

Name:

VAAL Mark

Address:

United States (US)

2

Name:

FERRARIS Dana

Address:

United States (US)

3

Name:

BELYAKOV Sergei

Address:

Singapore (SG)

4

Name:

HAMILTON Gregory

Address:

United States (US)

5

Name:

DUVALL Bridget

Address:

United States (US)

Priority

Priority Number:

167112 P

Priority Date:

06/04/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

C07H 19/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages